Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$7.89 USD
0.00 (0.00%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $7.95 +0.06 (0.76%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Avalo Therapeutics, Inc. has a market cap of $85.43M, which represents its share price of $7.89 multiplied by its outstanding shares number of 10.83M. As a small-cap company, AVTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AVTX 7.89 0.00(0.00%)
Will AVTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AVTX
12 Health Care Stocks Moving In Friday's Pre-Market Session
Avalo Therapeutics management to meet virtually with Piper Sandler
AVTX: Upcoming Virtual Meeting Hosted by Piper Sandler | AVTX Stock News
Avalo Therapeutics management to meet virtually with Piper Sandler
Avalo Therapeutics to Participate in Upcoming Investor Conferences | AVTX Stock News